FDA Inspection 1159391 — R2 Diagnostics, Inc.

R2 Diagnostics, Inc. — FEI 3000210416

The FDA completed an inspection of R2 Diagnostics, Inc. on Dec 9, 2021 in South Bend, IN. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Dec 9, 2021
Fiscal Year
2022
Product Type
Devices
Project Area
Compliance: Devices
Location
South Bend, IN (United States)

Citations

IDCFRDescription
367821 CFR 820.30(g)Design Validation - Risk analysis not performed/inadequate